Prime-boost strategies for malaria vaccine development
Author:
Dunachie Susanna J.1, Hill Adrian V. S.1
Affiliation:
1. Centre for Clinical Vaccinology and Tropical Medicine,, University of Oxford, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK
Abstract
SUMMARY
Malaria is an intracellular pathogen, for which an effective vaccine is likely to require induction of cell-mediated immunity. Immunisation approaches that stimulate strong and persistent levels of effector T-cells are being sought by many researchers. DNA vaccines, recombinant protein and viral vectors were amongst the vaccine delivery systems that appeared promising for the generation of cellular immunity, and in some initial studies in small animals this goal was achieved. However, clinical trials of these candidate vaccines when used alone or in repeated homologous boosting regimes have been disappointing, with short-lived low levels of induced specific T-cell responses. Recent years have seen the development of immunisation strategies using a combination of different antigen delivery systems encoding the same epitopes or antigen, delivered at an interval of a few weeks apart. This sequential immunisation approach with different vectors is known as heterologous prime-boosting and is capable of inducing greatly enhanced and persistent levels of CD8+ T-cells and Th1-type CD4+ T-cells compared to homologous boosting. This review will summarise the key pre-clinical studies of prime-boost strategy and outline recent progress in clinical trials of this approach. Possible mechanisms of action and potential improvements to existing delivery systems will be discussed. The prime-boost approach represents an encouraging step towards establishing an effective preventative vaccine to one of the world's greatest killers.
Publisher
The Company of Biologists
Subject
Insect Science,Molecular Biology,Animal Science and Zoology,Aquatic Science,Physiology,Ecology, Evolution, Behavior and Systematics
Reference63 articles.
1. Allen, T. M., Vogel, T. U., Fuller, D. H., Mothe, B. R.,Steffen, S., Boyson,
J. E., Shipley, T., Fuller, J., Hanke, T., Sette,A. et al. (2000). Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J. Immunol.164,4968-4978. 2. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H.,McHeyzer-
Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science274, 94-96. 3. Amara, R. R., Villinger, F., Altman, J. D., Lydy, S. L., O'Neil,S. P.,
Staprans, S. I., Montefiori, D. C., Xu, Y., Herndon, J. G.,Wyatt, L. S. et al. (2001). Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science292,69-74. 4. Belshe, R. B., Stevens, C., Gorse, G. J., Buchbinder, S.,Weinhold,
K., Sheppard, H., Stablein, D., Self, S., McNamara, J., Frey,S. et al. (2001). Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J. Infect. Dis.183,1343-1352. 5. Bruna-Romero, O., Gonzalez-Aseguinolaza, G., Hafalla, J. C.,Tsuji, M. and Nussenzweig, R. S. (2001). Complete,long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc. Natl. Acad. Sci. USA98,11491-11496.
Cited by
84 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|